VELOR
For laboratory research use only · Not for human consumption
Shop
FOCUS

Selank

10mg nasal
$40.00
Selank 10mg nasal product photograph
1
7 available · Ships within 48 hours
  • Third-Party Tested
  • Cold-Chain Handled
  • Concierge Support

Questions about this compound, specifications, or documentation?

Speak with the Concierge

Synthetic tuftsin analog referenced in published literature investigating GABAergic and serotonergic receptor pathway biology.

  • Neurocognitive signaling research
  • Nasal-route research form factor
  • Cold-chain handled, third-party tested
VIEW BATCH COA
Independent lab verification · current batch
  • THIRD-PARTY TESTED
  • COLD-CHAIN HANDLED
  • TRACKED SHIPPING
  • QUALITY-FOCUSED SOURCING
SPECIFICATIONS
Product
Selank
Strength
10mg nasal
Vial Size
10mg nasal per vial
SKU
VLR-SEL-10
Batch / Lot
Current batch listed on COA
Storage
Refrigerate 2–8°C · protect from light
Form
Lyophilized powder
RESEARCH USE ONLY

Sold strictly for laboratory and research purposes — never for human consumption, food, drug, or cosmetic use. 21+ only. A standard we hold ourselves to, not just the law.

EDUCATIONAL OVERVIEW

About this compound

Context, not noise — what the research actually says.

WHAT IT IS

A nasal research peptide investigated in neurocognitive signaling and BDNF-related pathway literature.

FOCUS
KEY BENEFITS
  • Studied in neurocognitive signaling pathways
  • Investigated in stress-response pathway research
  • Referenced in neurotrophic and synaptic-plasticity literature
COMMON USES
  • Neurocognitive signaling research
  • Stress-response pathway studies
  • Discreet daily research applications
THINGS TO KNOW
  • Nasal-route research peptide — store refrigerated
  • Protect from light; do not freeze
  • Research use only — not for human consumption
RELATED COLLECTION
Focus Research Collection

Pairs with Semax — Two short neuropeptides referenced together in neurocognitive signaling literature.

VIEW COLLECTION
COLLECTION PRICE
$70.00
STORAGE

Cold-chain handling

REFRIGERATED
Store unopened at 36–46°F (2–8°C).
RECONSTITUTED
Keep refrigerated. Do not freeze.
PROTECT FROM LIGHT
Original packaging until use.

Store unopened vials refrigerated at 36–46°F (2–8°C). After reconstitution, keep refrigerated and use within the timeframe specified by your laboratory practice. Protect from light. Do not freeze reconstituted solution.

SHIPPING

Shipping information

Insulated, tracked, and handled with care from our facility to yours.

PROCESSING
Ships within 48 hours of order confirmation.
COLD-CHAIN
Insulated packaging with ice packs for temperature-sensitive compounds.
TRACKED & INSURED
Tracking provided. Domestic delivery typically 2–5 business days.

Local pickup is available by appointment for customers in the Phoenix, Arizona area. See the full shipping policy for details, accepted payment methods, and scheduling.

FAQ

Common questions

SCIENTIFIC RESEARCH OVERVIEW · SRO

Scientific Research Overview

A structured summary of published scientific literature on this compound — provided for educational reference only.

Neuroscience Research
RESEARCH SNAPSHOT
Research Category
Investigational synthetic tuftsin analogue heptapeptide
Biological Targets
  • GABAergic signaling
  • Enkephalin system
  • Immune-neuroendocrine pathways
Primary Areas of Research
GABAergic-system signaling · Enkephalin-system biology · Neuroimmune interactions · Stress-response pathways · Cytokine and chemokine gene expression · Neurocognitive research
Current Stage of Research
Preclinical and Early Human Clinical Research
WHAT IS SELANK?

Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), investigated in the scientific literature for its effects on GABAergic signaling, enkephalin system activity, and immune-neuroendocrine interactions. It has been studied in preclinical models and in early human clinical research for anxiolytic-like, neurocognitive, and immunomodulatory properties.

PRIMARY AREAS OF RESEARCH
  • GABAergic-system signaling
  • Enkephalin-system biology
  • Neuroimmune interactions
  • Stress-response pathways
  • Cytokine and chemokine gene expression
  • Neurocognitive research

  • Published studies have investigated anxiolytic-like activity in preclinical models without the classical sedative or muscle-relaxant effects observed with some traditional anxiolytic agents.
  • Research suggests modulation of GABA-receptor subunit expression and GABAergic neurotransmission in cell-based and animal models.
  • Current evidence indicates inhibition of enkephalin-degrading enzymes and effects on enkephalin activity in blood and neural tissue in reported datasets.
  • Investigators have observed changes in cytokine, chemokine, and neuroimmune gene-expression profiles in preclinical models and early human studies.

Selank is being studied for its ability to influence GABAergic neurotransmission, including modulation of GABA-receptor subunit gene expression, and to inhibit enkephalin-degrading enzymes such as prolyl endopeptidase. Current evidence indicates that these actions may affect enkephalin half-life and GABAergic tone. Published work also suggests broader immunomodulatory effects, including altered expression of genes involved in cytokine and chemokine signaling, linking central nervous system activity with neuroimmune pathways.
CURRENT AREAS OF INVESTIGATION
  • Neurocognitive Research
  • Stress Response
  • Inflammation
  • GABAergic Signaling
  • Neuroimmune Research
  • Healthy Aging

  1. Filatova E, Kasian A, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31. View source
  2. Filatova E, Kasian A, Kolomin T, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Front Pharmacol. 2017;8:89. View source
  3. Volkova A, Shadrina M, Kolomin T, et al. The Inhibitory Effect of Selank on Enkephalin-Degrading Enzymes as a Possible Mechanism of Its Anxiolytic Activity. Izv Akad Nauk Ser Biol. 2001;(4):419–423. View source
  4. Uchakina ON, et al. [Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalized Anxiety Disorders and Neurasthenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(2):38–48. View source
  5. Kolomin T, Shadrina M, Slominsky PA, et al. Peptide-Based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Int J Mol Sci. 2018;19(9):2702. View source
RESEARCH STATUS

This compound continues to be investigated in preclinical and/or clinical research. Scientific understanding continues to evolve as additional studies are published.

RESEARCH DISCLAIMER

For laboratory research use only. This information summarizes published scientific literature for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

RELATED · FOCUS

More from this pillar

VIEW ALL
RESEARCH DISCLAIMER

All VELOR compounds are sold strictly for laboratory and research purposes only. They are not intended for human consumption, ingestion, or any food, drug, cosmetic, or therapeutic use. By purchasing, you confirm you are 21+ and a qualified researcher or research institution. Statements have not been evaluated by the FDA.

FOCUS
Selank
$40.00
1